ISPOR Code of Ethics for Researchers Background Article - Report of the ISPOR Task Force on Code of Ethics for Researchers

Value in Health

Volumn 7, Issue 2, 2004, Pages 111-117

  Palumbo, Francis B ^a   Barnes, Rod ^b   Deverka, Patricia ^c   McGhan, William ^d   Mullany, Lawrence ^e   Wertheimer, Albert ^f  

^a UNIVERSITY OF MARYLAND   (United States)

^b ALCON RESEARCH LTD   (United States)

^c Medco Health Solutions   (United States)

^d UNIVERSITY OF THE SCIENCES   (United States)

^e AvMed Health Plan   (United States)

^f TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Ethics; Publication; Research; Researchers; Sponsorship

Indexed keywords

ARTICLE; BOARD OF TRUSTEES; CLINICAL RESEARCH; FINANCIAL MANAGEMENT; INTERNET; MEDICAL ETHICS; MEDICAL INFORMATION; ONLINE SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PUBLICATION; REVIEW;

EID: 1842614105     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2004.72366.x     Document Type: Article

References (13)

1. Barnes R, Heaton A. Panel 6. Addressing questions of bias, credibility, and quality in health economic evaluations. Value Health 1999;2:99-102.
2. Mauskopf J. Industry responsibility in interactive computer modeling. Med Care 1996;34:DS165-72.
3. Blades C, Culyer A, Walker A. Health service efficiency: appraising the appraisers - a critical review of economic appraisal in practice. Soc Sci Med 1981;24:461-72.
4. Kassirer JP, Angel M. The journal's policy on cost-effectiveness analyses. N Engl J Med 1994;331:669-70.
5. Hillman AL, Eisenberg JM, Pauly MV, et al. Sounding board, avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med 1991;324:1362-5.
6. Hillman AL, et al. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of healthcare technology: a report on principles. Ann Intern Med 1995;123:61-70.
7. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials, explanation and elaboration. Ann Intern Med 2001;134:663-94.
8. Department of Health Education and Welfare. The Belmont Report. Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Bethesda: The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979 Apr 18.
9. Bradley CA, Iskedjian M, Lanctot KL, et al. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals. Ann Pharmacother 1995;29:681-9.
10. Schulman KA, Rubinstein LE, Click HA, Eisenberg JM. Relationships between sponsors and investigators in pharmacoeconomic and clinical research. Pharmacoeconomics 1995;7:206-20.
11. Yee GC, Hillman AL. Applied pharmacoeconomics: when can publication be legitimately withheld? Pharmacoeconomics 1997;12:511-6.
12. Schulman KA, Seils DM, Timbie JW, et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 2002;347:1335-41.
13. JAMA instructions to authors. Authorship responsibility, criteria, and contributions. JAMA 2002;287:128.